Silver Point Capital, 10% Owner: Keenova Therapeutics Buy · Filed 25/11/19

Trade details

Type: Insider buy
Amount: $3,732,960
Shares · price: 42,000 sh · $88.88 a share
Held after: 4,571,740 sh
Stock: Keenova Therapeutics
Person: Silver Point Capital10% Owner
Trade date: 25/11/19
Filed: 25/11/19
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: +0.9%

Keenova Therapeutics trades, last 26 weeks

Silver Point Capital's recent trades

Silver Point Capital10% Stockholder
Planned saleQVC Group
Planned sale
QVC Group
QVCG
$11.8M
720,000 sh
$11.8M
Filed 09/03
Traded 09/03
Silver Point Capital10% Stockholder
Planned saleQVC Group
Planned sale
QVC Group
QVCG
$875K
50,000 sh
$875K
Filed 08/11
Traded 08/11
Silver Point Capital10% Owner
BuyKeenova Therapeutics
Buy
Keenova Therapeutics
$19M
210,000 sh
$19M
Filed 05/21
Traded 05/20
Silver Point Capital10% Owner
BuyKeenova Therapeutics
Buy
Keenova Therapeutics
$17M
187,500 sh
$17M
Filed 05/21
Traded 05/19
Silver Point Capital10% Owner
BuyKeenova Therapeutics
Buy
Keenova Therapeutics
$37.1M
410,000 sh
$37.1M
Filed 04/17
Traded 04/17